怡和嘉业(301367) - 2024年7月5日投资者关系活动记录表
BMCBMC(SZ:301367)2024-07-05 08:35

Company Overview - Beijing Yihe Jiaye Medical Technology Co., Ltd. was established in 2001 and launched its first multi-channel sleep monitor in 2003. The first sleep respirator was released in 2007, and the company received FDA certification in 2008. [1] - The company specializes in providing comprehensive treatment solutions for patients with Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD), focusing on both medical institutions and home care. [1] - Yihe Jiaye is a leading domestic company in non-invasive respiratory machines and ventilation masks, being the first domestic listed company to receive FDA certification for non-invasive respiratory products, with sales in over 100 countries and regions. [1] Market and Brand Strategy - The company is experiencing a gradual reduction in inventory pressure in the U.S. market, with expectations for improvement by Q3 2024. [2] - BMC is the main international brand, registered in nearly 60 countries, while Ruimai Te is the primary domestic brand, having obtained trademark rights in about 20 categories. [2] - The company has a strong understanding of global medical device regulations and has established a comprehensive patent and trademark layout in major markets. [3] Impact of Aging Population - The aging population is driving the demand for home respiratory machines, as older adults represent a significant target audience for CPAP devices. [3] Financial Performance and Currency Impact - In 2022, overseas revenue accounted for approximately 85% of total revenue, decreasing to about 65% in 2023. Currency fluctuations, particularly in USD, have a positive impact on net profit. [3]

BMC-怡和嘉业(301367) - 2024年7月5日投资者关系活动记录表 - Reportify